EUVIMEDEUVIMED entdecken
Open Access

Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex

Taygun C Uzuneser iD, Hanna J Szkudlarek iD, Matthew J Jones, Mina G Nashed iD, Timothy Clement, Hehe Wang iD, Iwao Ojima iD, Walter J Rushlow, Steven R Laviolette iD

Cerebral Cortex · 2023

DOI: 10.1093/cercor/bhac220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebral Cortex, 2023. Verfasst von Taygun C Uzuneser und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, 1151 Richmond Street, Medical Sciences Building, University of Wes…. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Anxiety, Fatty Acid-Binding Proteins, Prefrontal Cortex. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, National Institutes of Health, Artelo Biosciences and MITACs CANADA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endocannabinoid (eCB) system represents a promising neurobiological target for novel anxiolytic pharmacotherapies. Previous clinical and preclinical evidence has revealed that genetic and/or pharmacological manipulations altering eCB signaling modulate fear and anxiety behaviors. Water-insoluble eCB lipid anandamide requires chaperone proteins for its intracellular transport to degradation, a process that requires fatty acid-binding proteins (FABPs). Here, we investigated the effects of a novel FABP-5 inhibitor, SBFI-103, on fear and anxiety-related behaviors using rats. Acute intra-prelimbic cortex administration of SBFI-103 induced a dose-dependent anxiolytic response and reduced contextual fear expression. Surprisingly, both effects were reversed when a cannabinoid-2 receptor (CB2R) antagonist, AM630, was co-infused with SBFI-103. Co-infusion of the cannabinoid-1 receptor antagonist Rimonabant with SBFI-103 reversed the contextual fear response yet showed no reversal effect on anxiety. Furthermore, in vivo neuronal recordings revealed that intra-prelimbic region SBFI-103 infusion altered the activity of putative pyramidal neurons in the basolateral amygdala and ventral hippocampus, as well as oscillatory patterns within these regions in a CB2R-dependent fashion. Our findings identify a promising role for FABP5 inhibition as a potential target for anxiolytic pharmacotherapy. Furthermore, we identify a novel, CB2R-dependent FABP-5 signaling pathway in the PFC capable of strongly modulating anxiety-related behaviors and anxiety-related neuronal transmission patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsAnxietyFatty Acid-Binding ProteinsPrefrontal CortexReceptor, Cannabinoid, CB2AnimalsRatsAmygdalaCannabinoidsEndocannabinoidsFearHippocampusReceptor, Cannabinoid, CB1Eye ProteinsNerve Tissue ProteinsBenzofuransEthers, Cyclic

Stichwörter der Autor:innen

endocannabinoidsfatty acid binding protein-5in vivo electrophysiologypharmacotherapyprelimbic cortex

Substanzen

Anti-Anxiety AgentsCannabinoidsEndocannabinoidsFatty Acid-Binding ProteinsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Cnr2 protein, ratFabp5 protein, ratEye ProteinsNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Anatomy and Cell Biology, Schulich School of Medicine and Dentistry, 1151 Richmond Street, Medical Sciences Building, University of Western Ontario, London, ON N6A 3K7, Canada.
  • Institute of Chemical Biology and Drug Discoveries, 100 Nicolls Road, Stony Brook University, Stony Brook, NY 11794-3400, United States.
  • Department of Chemistry, 100 Nicolls Road, Stony Brook University, Stony Brook, NY 11794-3400, United States.
  • Department of Psychiatry, Schulich School of Medicine and Dentistry, 1151 Richmond Street, Mental Health Care Building, University of Western Ontario, London, ON N6A 3K7, Canada.

ORCID-Profile: Taygun C Uzuneser, Hanna J Szkudlarek, Mina G Nashed, Hehe Wang, Iwao Ojima, Steven R Laviolette

Förderung

  • NIDA NIH HHS
  • National Institutes of Health
  • Artelo Biosciences and MITACs CANADA

Zitieren

APA

Uzuneser, T. C., Szkudlarek, H. J., Jones, M. J., Nashed, M. G., Clement, T., Wang, H., Ojima, I., Rushlow, W. J., & Laviolette, S. R. (2023). Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex. Cerebral Cortex. https://doi.org/10.1093/cercor/bhac220

Vancouver

Uzuneser TC, Szkudlarek HJ, Jones MJ, Nashed MG, Clement T, Wang H, et al. Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex. Cerebral Cortex. 2023. doi:10.1093/cercor/bhac220

BibTeX
@article{Uzuneser2023,
  author = {Uzuneser, Taygun C and Szkudlarek, Hanna J and Jones, Matthew J and Nashed, Mina G and Clement, Timothy and Wang, Hehe and Ojima, Iwao and Rushlow, Walter J and Laviolette, Steven R},
  title = {Identification of a novel fatty acid binding protein-5-CB2 receptor-dependent mechanism regulating anxiety behaviors in the prefrontal cortex},
  journal = {Cerebral Cortex},
  year = {2023},
  doi = {10.1093/cercor/bhac220}
}
Kostenlos starten →